Description
TETRABENZAPINE 25MG TABLETS FOR PATIENT THERAPY
First action · last action
2011-09-16 · 2011-10-14
Transactions
2
First transaction's obligation
$43,178
Base + all options value (sum of deltas)
$0
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5010B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-09-16+$43,178= $43,178
- Mod P000012011-10-14-$43,178= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-09-16 | +$43,178 | $43,178 | TETRABENZAPINE 25MG TABLETS FOR PATIENT THERAPY |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2011-10-14 | −$43,178 | $0 | TETRABENZAPINE 25MG TABLETS FOR PATIENT THERAPY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F1M3L99R99B3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0172 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24920N0537 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $25,476 | FY2020 |
| 36C24920N0520 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $20,381 | FY2020 |
| 36C24920N0515 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
| 36C24920N0502 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
| 36C24920N0482 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
Other recipients under 6505 from 531-BOISE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26012F0147 | PFIZER INC. | 531-BOISE | $27,633 | FY2012 |
| VA531C21513 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 531-BOISE | $200,427 | FY2011 |
| VA668C21500 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 531-BOISE | $142,205 | FY2011 |
| VA653C21506 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 531-BOISE | $78,997 | FY2011 |
| VA531A11003 | SANOFI VACCINES US INC. | 531-BOISE | $97,740 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA531C21533_3600_V797P5010B_3600 · retrieved 2026-09-26.